S. 1862

Summary

S. 1862, the ORPHAN Cures Act, was introduced in the Senate on May 22, 2025 by Sen. John Barrasso (R) with 1 co-sponsor. It was referred to Finance, and last saw action on May 22, 2025: Read twice and referred to the Committee on Finance. (text: CR S3119).

Record

Text

S. 1862 has 1 co-sponsor.

119 S1862 IS: Optimizing Research Progress Hope And New Cures Act
 U.S. Senate
 2025-05-22
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  II
  119th CONGRESS
  1st Session
  S. 1862
  IN THE SENATE OF THE UNITED STATES
  May 22, 2025
  Mr. Barrasso  (for himself and  Mr. Heinrich ) introduced the following bill; which
  was read twice and referred to the  Committee
  on Finance
  A BILL
To amend title XI of the Social Security Act to expand and clarify the
  exclusion for orphan drugs under the Drug Price Negotiation Program.
1.
Short title
This Act may be cited as the   Optimizing Research Progress Hope And New Cures Act   or the   ORPHAN Cures Act  .
2.
Expanding and clarifying the exclusion for orphan drugs under the Drug Price
  Negotiation Program
Section 1192(e) of the Social Security Act ( 42 U.S.C. 1320f–1(e) ) is amended—
(1)
in paragraph (1), by adding at the end the following new subparagraph:
(C)
Treatment of former orphan drugs
In calculating the amount of time that has elapsed with respect to the approval of a drug or licensure of a biological product under subparagraph (A)(ii) and subparagraph (B)(ii), respectively, the Secretary shall not take into account any period during which such drug or product was a drug described in paragraph (3)(A).
  ; and
(2)
in paragraph (3)(A)—
(A)
by striking  only one rare disease or condition  and inserting  one or more rare diseases or conditions ; and
(B)
by striking  such disease or condition  and inserting  one or more rare diseases or conditions (as such term is defined in section 526(a)(2) of the Federal Food, Drug, and Cosmetic Act) .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Sen. John Barrasso (R) sponsors S. 1862, and 1 member has co-sponsored it from the day it was introduced.

John Barrasso

Sen. · R–WY · Sponsor

Introduced May 22, 2025

Martin Heinrich

Sen. · D–NM · Co-sponsor

Joined May 22, 2025 · Original

Show 2 of 2 rows

PreviousNext

Committees

S. 1862 went before 1 committee: Finance.

Finance

Finance

Referred To · May 22, 2025 · 902 Bills

Actions

S. 1862 has taken 2 actions since May 22, 2025.

Votes

S. 1862 has not gone to a roll call.

Related bills

1 bill is related to S. 1862.

HR 946ORPHAN Cures ActFeb 6, 2025 · Sponsor introductory remarks on measure. (CR H535-536) · Related bill

Show 1 of 1 row

PreviousNext

Titles

S. 1862 goes by 4 titles, 2 of them short titles.

• ORPHAN Cures Act — Display Title
• ORPHAN Cures Act — Short Title(s) as Introduced
• Optimizing Research Progress Hope And New Cures Act — Short Title(s) as Introduced
• A bill to amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program. — Official Title as Introduced

Lobbying

28 clients hired 19 firms and 103 registered lobbyists who named S. 1862 in 96 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark, Pharmacy, Trade (domestic/foreign), Budget/Appropriations, Defense.

Clients

Who paid to be heard, by how many filings named the bill. The 20 that filed most often, of 28.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 103.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files S. 1862 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 1862’s is Health.

Source: congress.gov · legiscan.com